Pharmacopsychiatry

Papers
(The H4-Index of Pharmacopsychiatry is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels126
Review and Consensus on Pharmacogenomic Testing in Psychiatry105
The History of Psychedelics in Psychiatry70
Classic Psychedelic Drugs: Update on Biological Mechanisms41
Psychedelics and Psychotherapy37
Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders34
Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports32
Candidate Psychotropics against SARS – CoV – 2: A Narrative Review23
Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry16
Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer’s Disease16
Opioid Mortality Following Implementation of Medical Cannabis Programs in the United States15
The Potential Role of Psychedelic Drugs in Mental Health Care of the Future15
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice15
Neurotrophic Properties of Silexan, an Essential Oil from the Flowers of Lavender-Preclinical Evidence for Antidepressant-Like Properties15
Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update14
0.53717017173767